Biocon shares: Biocon’s Board will meet on Saturday, December 6, 2025, to decide on key proposals that could shape its growth and shareholder value. A major agenda item is a potential investment in its unlisted arm, Biocon Biologics either through cash or preferential allotment to boost its stake and support long-term expansion.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets